Pharmacor® Patient Flow Models™
Key Benefits
- Trending functions allow users to track changes in population dynamics, survival and disease recurrence over time
- Annualized 15-year patient forecast
- Coverage of the U.S., EU5 and Japan
- Key sub-population analyses
- Interactive Excel-based tool
- Fully transparent modeling methods and sources
Key Users
- Market Analytics
- Market Research
- Health Economics and Outcomes
- Business Development
- New Product Planning
Understand Patient Flows and Populations for Market Forecast Development
Patient flow models are vital resources for building and validating bottom up market forecasts. Pharmacor Patient Flow Models give users access to accurate patient population sizes and provide clearly depicted underlying methodology and transparent assumptions to help quantify market size and untapped market potential within multiple lines of therapy.
Whether used as a starting point to develop a custom model or to validate the logic behind an existing internal model, Pharmacor Patient Flow Models allow users to generate detailed and robust estimates of epidemiological and market populations, while tracking exactly how each estimate was made.
Features
- Detailed estimates of patient population sizes and estimates of drug-treatment opportunities by:
- Country
- Forecast year
- Line of therapy
- Stage of disease at diagnosis
- Interactive analytical interface that allows users to track trends in survival, drug-treated percentages, recurrence rate, incidence, prevalence and many other epidemiological parameters over a 15-year forecast period
- Graphical description of the most commercially pertinent indication-specific patient flows and populations, as well as a detailed graphical description of the epidemiological model and its parameters used to estimate each patient flow and population